• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调强放疗时代基于定量唾液腺闪烁扫描法对唾液腺耐受剂量的前瞻性研究及文献综述

Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.

作者信息

Lee Sea-Won, Kang Keon Wook, Wu Hong-Gyun

机构信息

Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.

Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Head Neck. 2016 Apr;38 Suppl 1:E1746-55. doi: 10.1002/hed.24310. Epub 2016 Feb 15.

DOI:10.1002/hed.24310
PMID:26875880
Abstract

BACKGROUND

The purpose of this study was to prospectively evaluate the scintigraphic results on patients who undergo intensity-modulated radiotherapy (IMRT) to investigate the tolerance doses for the salivary glands.

METHODS

Salivary scintigraphy was performed on 35 patients with head and neck cancer before the beginning of radiotherapy (RT), and then at 6 weeks and again at 3 months after the completion of RT. Xerostomia was recorded according to the Radiation Therapy and Oncology Group (RTOG) grade. Salivary function was evaluated by calculating the excretion rate changes (ΔF) for each salivary gland before and after RT.

RESULTS

The parotid mean dose was significantly related to parotid ΔF and the submandibular gland mean dose to the submandibular gland ΔF. The parotid mean dose of 23 Gy was best correlated with the RTOG grades. The submandibular gland mean dose significantly related to ΔF ≤-50% and ≤-75% was 42 Gy.

CONCLUSION

The parotid mean dose of 23 Gy and the submandibular gland mean dose of 42 Gy is feasible for salivary function preservation in the IMRT era. © 2016 Wiley Periodicals, Inc. Head Neck 38: E1746-E1755, 2016.

摘要

背景

本研究旨在前瞻性评估接受调强放疗(IMRT)患者的闪烁扫描结果,以研究唾液腺的耐受剂量。

方法

对35例头颈部癌患者在放疗(RT)开始前进行唾液闪烁扫描,然后在放疗结束后6周和3个月时再次进行扫描。根据放射治疗肿瘤学组(RTOG)分级记录口干情况。通过计算放疗前后各唾液腺的排泄率变化(ΔF)来评估唾液功能。

结果

腮腺平均剂量与腮腺ΔF显著相关,下颌下腺平均剂量与下颌下腺ΔF显著相关。腮腺平均剂量23 Gy与RTOG分级相关性最佳。与ΔF≤ -50%和≤ -75%显著相关的下颌下腺平均剂量为42 Gy。

结论

在IMRT时代,腮腺平均剂量23 Gy和下颌下腺平均剂量42 Gy对保留唾液功能是可行的。© 2016威利期刊公司。《头颈》38: E1746 - E1755, 2016。

相似文献

1
Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.调强放疗时代基于定量唾液腺闪烁扫描法对唾液腺耐受剂量的前瞻性研究及文献综述
Head Neck. 2016 Apr;38 Suppl 1:E1746-55. doi: 10.1002/hed.24310. Epub 2016 Feb 15.
2
Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.通过定量高锝酸盐闪烁扫描术测量头颈部肿瘤放疗后唾液腺功能的变化:调强放疗与常规放疗联合或不联合氨磷汀的比较
Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):651-9. doi: 10.1016/j.ijrobp.2006.09.035. Epub 2006 Dec 15.
3
Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.用高锝酸盐定量闪烁扫描术评估调强放疗治疗头颈部肿瘤后唾液腺功能
Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):175-84. doi: 10.1016/s0360-3016(03)01437-8.
4
Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.头颈部癌症调强放疗后唾液功能的闪烁评估:与腮腺剂量和生活质量的相关性。
Oral Oncol. 2013 Jan;49(1):42-8. doi: 10.1016/j.oraloncology.2012.07.004. Epub 2012 Jul 31.
5
Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.头颈部癌症患者接受或不接受对侧颌下腺保护的调强放疗后唾液腺剂量对唾液分泌和口干程度恢复的影响:一项纵向研究。
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1479-87. doi: 10.1016/j.ijrobp.2010.07.1990. Epub 2010 Oct 8.
6
Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.头颈部癌患者的调强放疗或容积调强弧形放疗:聚焦于唾液腺剂量测定。
Head Neck. 2016 Jul;38(7):1028-34. doi: 10.1002/hed.24398. Epub 2016 Feb 8.
7
Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.头颈部癌患者术后放疗时腮腺和颌下腺的放射性体积变化:一项纵向研究
Laryngoscope. 2009 Oct;119(10):1966-74. doi: 10.1002/lary.20601.
8
Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.基于主要涎腺的观察剂量反应的头颈部强度调制放射治疗的准确性要求。
Radiother Oncol. 2009 Oct;93(1):109-14. doi: 10.1016/j.radonc.2009.04.023. Epub 2009 May 10.
9
A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.一项II期研究,旨在评估氨磷汀在对头颈部癌进行调强放射治疗以保留腮腺唾液时,对保留下颌下腺/舌下腺唾液的疗效。
Semin Oncol. 2004 Dec;31(6 Suppl 18):25-8. doi: 10.1053/j.seminoncol.2004.12.008.
10
[Normal tissue tolerance to external beam radiation therapy: salivary glands].[正常组织对外照射放射治疗的耐受性:唾液腺]
Cancer Radiother. 2010 Jul;14(4-5):290-4. doi: 10.1016/j.canrad.2010.03.007. Epub 2010 Jul 6.

引用本文的文献

1
Assessment and Prediction of Salivary Gland Function After Head and Neck Radiotherapy: A Systematic Review.头颈部放疗后唾液腺功能的评估与预测:一项系统评价
Cancer Med. 2024 Dec;13(24):e70494. doi: 10.1002/cam4.70494.
2
Chemotherapy/Radiotherapy-Induced Dysphagia in Head and Neck Tumors: A Challenge for Otolaryngologists in Low- to Middle-Income Countries.头颈部肿瘤化疗/放疗所致吞咽困难:低收入和中等收入国家耳鼻喉科医生面临的挑战
Dysphagia. 2024 Sep 24. doi: 10.1007/s00455-024-10756-5.
3
Research Value of Intensity Modulated Radiation Therapy in Alleviating Parotid Gland Function Injury in Patients with Stage N0 Nasopharyngeal Carcinoma from Physical and Dosimetric Aspects.
从物理和剂量学方面评估调强放疗减轻 N0 期鼻咽癌患者腮腺功能损伤的研究价值。
Comput Math Methods Med. 2022 Jul 11;2022:4651364. doi: 10.1155/2022/4651364. eCollection 2022.
4
Can the Risk of Dysphagia in Head and Neck Radiation Therapy Be Predicted by an Automated Transit Fluence Monitoring Process During Treatment? A First Comparative Study of Patient Reported Quality of Life and the Fluence-Based Decision Support Metric.头颈部放射治疗中吞咽困难的风险能否通过治疗期间的自动传输通量监测过程来预测?基于患者报告的生活质量和通量的决策支持指标的首次比较研究。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027906. doi: 10.1177/15330338211027906.
5
Evaluation of Aquaporins 1 and 5 Expression in Rat Parotid Glands After Volumetric Modulated Arc Radiotherapy and Use of Low-Level Laser Therapy at Different Times.容积调强弧形放疗后不同时间使用低强度激光治疗对大鼠腮腺水通道蛋白1和5表达的评估
J Lasers Med Sci. 2020 Summer;11(3):262-267. doi: 10.34172/jlms.2020.44. Epub 2020 Jun 21.
6
Investigation of a Novel Decision Support Metric for Head and Neck Adaptive Radiation Therapy Using a Real-Time Portal Dosimetry System.使用实时 portal 剂量测定系统对头颈部自适应放射治疗的新型决策支持指标的研究。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819873629. doi: 10.1177/1533033819873629.